WAVE Life Sciences (WVE.US): The 2024 Q1 financial report achieved revenue of US$12.538 million, previous value of US$12.929 million, expected value of US$22.95 million; earnings per share were -0.24 USD, previous value of -0.27 USD, and expected value of -0.21 USD.
WAVE Life Sciences(WVE.US)：2024年Q1财报实现营收1253.8万美元，前值为1292.9万美元，预期值为2295万美元；每股收益为-0.24美元，前值为-0.27美元，预期值为-0.21美元。
WAVE Life Sciences (WVE.US): The 2024 Q1 financial report achieved revenue of US$12.538 million, previous value of US$12.929 million, expected value of US$22.95 million; earnings per share were -0.24 USD, previous value of -0.27 USD, and expected value of
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.